arrow
T

Thomas Illig

Hannover Medical School
H指数:103
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Improved functional JAG1 and NOTCH2 variant testing in patients with clinical or suspected Alagille syndrome using new low-Notch activity cells

改进的临床或疑似Alagille综合征患者中功能性JAG1和NOTCH2变异检测,使用新的低Notch活性细胞

2026-04-180
OAAI
Headspace SPME GC–MS Analysis of Urinary Volatile Organic Compounds (VOCs) for Classification Under Sample-Limited Conditions

顶空固相微萃取-气相色谱-质谱分析尿液挥发性有机化合物(VOCs)在样本有限条件下的分类

2026-01-090
OAAI
Vaccination Schedule and Age Influence Impaired Responsiveness to Hepatitis B Vaccination: A Randomized Trial in Central Asia
2024-12-090
OAAI
The RESIST Senior Individuals Cohort: Design, participant characteristics and aims (Aug, 10.1007/s11357-024-01299-6, 2024)
2024-10-220
OAAI
Loss of atrial natriuretic peptide signaling causes insulin resistance, mitochondrial dysfunction, and low endurance capacity
2024-10-110
OAAI
The RESIST Senior Individuals Cohort: Design, participant characteristics and aims
2024-08-142
OAAI
A precise performance-based reimbursement model for the multi-centre NAPKON cohorts - development and evaluation
2024-06-130
OAAI
Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany
2023-10-172
OAAI
Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19
2023-02-019
OAAI
Canine real-time detection of SARS-CoV-2 infections in the context of a mass screening event

在大规模筛查事件的背景下,犬实时检测SARS-CoV-2感染

2022-11-119
OAAI
The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling

肺新型冠状病毒肺炎的致命轨迹是由小叶缺血和纤维化重塑驱动的

2022-11-0127
OAAI